 | • レポートコード：GIR201100587 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、アムロジピン及びオルメサルタンの世界市場を調査対象にし、アムロジピン及びオルメサルタンの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（5/20mg錠、10/20mg錠、5/40mg錠、10/40mg錠）、用途別分析（病院、ドラッグストア）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Daiichi Sankyo、Alembic Pharmaceuticals、Matrix Laboratories、Teva、Macleods Pharmaceuticals、Glenmark Pharmaceuticals、Jubilant Pharma、Aurobindo、Torrent Pharmaceuticals、Ajanta Pharma、Accord Healthcare ・メーカー別販売量、売上、市場シェア ・アムロジピン及びオルメサルタンの地域別市場分析 ・アムロジピン及びオルメサルタンの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・アムロジピン及びオルメサルタンのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・アムロジピン及びオルメサルタンのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・アムロジピン及びオルメサルタンの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・アムロジピン及びオルメサルタンの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・アムロジピン及びオルメサルタンの種類別市場規模2015-2020：5/20mg錠、10/20mg錠、5/40mg錠、10/40mg錠 ・アムロジピン及びオルメサルタンの用途別市場規模2015-2020：病院、ドラッグストア ・アムロジピン及びオルメサルタンの世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Amlodipine and Olmesartan market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Amlodipine and Olmesartan market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Amlodipine and Olmesartan market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Amlodipine and Olmesartan market has been segmented into
5/20 mg Tablets
10/20 mg Tablets
5/40 mg Tablets
10/40 mg Tablets
By Application, Amlodipine and Olmesartan has been segmented into:
Hospital
Drug store
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Amlodipine and Olmesartan market presented in the report. This section sheds light on the sales growth of different regional and country-level Amlodipine and Olmesartan markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Amlodipine and Olmesartan market.
The report offers in-depth assessment of the growth and other aspects of the Amlodipine and Olmesartan market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Amlodipine and Olmesartan Market Share Analysis
Amlodipine and Olmesartan competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Amlodipine and Olmesartan sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Amlodipine and Olmesartan sales, revenue and market share for each player covered in this report.
The major players covered in Amlodipine and Olmesartan are:
Daiichi Sankyo
Alembic Pharmaceuticals
Matrix Laboratories
Teva
Macleods Pharmaceuticals
Glenmark Pharmaceuticals
Jubilant Pharma
Aurobindo
Torrent Pharmaceuticals
Ajanta Pharma
Accord Healthcare
Among other players domestic and global, Amlodipine and Olmesartan market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Amlodipine and Olmesartan product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Amlodipine and Olmesartan, with price, sales, revenue and global market share of Amlodipine and Olmesartan in 2018 and 2019.
Chapter 3, the Amlodipine and Olmesartan competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Amlodipine and Olmesartan breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Amlodipine and Olmesartan market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Amlodipine and Olmesartan sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Amlodipine and Olmesartan Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Amlodipine and Olmesartan Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 5/20 mg Tablets
1.2.3 10/20 mg Tablets
1.2.4 5/40 mg Tablets
1.2.5 10/40 mg Tablets
1.3 Market Analysis by Application
1.3.1 Overview: Global Amlodipine and Olmesartan Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Drug store
1.4 Overview of Global Amlodipine and Olmesartan Market
1.4.1 Global Amlodipine and Olmesartan Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Daiichi Sankyo
2.1.1 Daiichi Sankyo Details
2.1.2 Daiichi Sankyo Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Daiichi Sankyo SWOT Analysis
2.1.4 Daiichi Sankyo Product and Services
2.1.5 Daiichi Sankyo Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Alembic Pharmaceuticals
2.2.1 Alembic Pharmaceuticals Details
2.2.2 Alembic Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Alembic Pharmaceuticals SWOT Analysis
2.2.4 Alembic Pharmaceuticals Product and Services
2.2.5 Alembic Pharmaceuticals Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Matrix Laboratories
2.3.1 Matrix Laboratories Details
2.3.2 Matrix Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Matrix Laboratories SWOT Analysis
2.3.4 Matrix Laboratories Product and Services
2.3.5 Matrix Laboratories Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Teva
2.4.1 Teva Details
2.4.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Teva SWOT Analysis
2.4.4 Teva Product and Services
2.4.5 Teva Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Macleods Pharmaceuticals
2.5.1 Macleods Pharmaceuticals Details
2.5.2 Macleods Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Macleods Pharmaceuticals SWOT Analysis
2.5.4 Macleods Pharmaceuticals Product and Services
2.5.5 Macleods Pharmaceuticals Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Glenmark Pharmaceuticals
2.6.1 Glenmark Pharmaceuticals Details
2.6.2 Glenmark Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Glenmark Pharmaceuticals SWOT Analysis
2.6.4 Glenmark Pharmaceuticals Product and Services
2.6.5 Glenmark Pharmaceuticals Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Jubilant Pharma
2.7.1 Jubilant Pharma Details
2.7.2 Jubilant Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Jubilant Pharma SWOT Analysis
2.7.4 Jubilant Pharma Product and Services
2.7.5 Jubilant Pharma Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Aurobindo
2.8.1 Aurobindo Details
2.8.2 Aurobindo Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Aurobindo SWOT Analysis
2.8.4 Aurobindo Product and Services
2.8.5 Aurobindo Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Torrent Pharmaceuticals
2.9.1 Torrent Pharmaceuticals Details
2.9.2 Torrent Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Torrent Pharmaceuticals SWOT Analysis
2.9.4 Torrent Pharmaceuticals Product and Services
2.9.5 Torrent Pharmaceuticals Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Ajanta Pharma
2.10.1 Ajanta Pharma Details
2.10.2 Ajanta Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Ajanta Pharma SWOT Analysis
2.10.4 Ajanta Pharma Product and Services
2.10.5 Ajanta Pharma Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Accord Healthcare
2.11.1 Accord Healthcare Details
2.11.2 Accord Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Accord Healthcare SWOT Analysis
2.11.4 Accord Healthcare Product and Services
2.11.5 Accord Healthcare Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Amlodipine and Olmesartan Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Amlodipine and Olmesartan Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Amlodipine and Olmesartan Manufacturer Market Share in 2019
3.3.2 Top 6 Amlodipine and Olmesartan Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Amlodipine and Olmesartan Sales, Revenue and Market Share by Regions
4.1.1 Global Amlodipine and Olmesartan Sales and Market Share by Regions (2015-2020)
4.1.2 Global Amlodipine and Olmesartan Revenue and Market Share by Regions (2015-2020)
4.2 North America Amlodipine and Olmesartan Sales and Growth Rate (2015-2020)
4.3 Europe Amlodipine and Olmesartan Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Amlodipine and Olmesartan Sales and Growth Rate (2015-2020)
4.5 South America Amlodipine and Olmesartan Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Amlodipine and Olmesartan Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Amlodipine and Olmesartan Sales, Revenue and Market Share by Country
5.1.1 North America Amlodipine and Olmesartan Sales and Market Share by Country (2015-2020)
5.1.2 North America Amlodipine and Olmesartan Revenue and Market Share by Country (2015-2020)
5.2 United States Amlodipine and Olmesartan Sales and Growth Rate (2015-2020)
5.3 Canada Amlodipine and Olmesartan Sales and Growth Rate (2015-2020)
5.4 Mexico Amlodipine and Olmesartan Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Amlodipine and Olmesartan Sales, Revenue and Market Share by Country
6.1.1 Europe Amlodipine and Olmesartan Sales and Market Share by Country (2015-2020)
6.1.2 Europe Amlodipine and Olmesartan Revenue and Market Share by Country (2015-2020)
6.2 Germany Amlodipine and Olmesartan Sales and Growth Rate (2015-2020)
6.3 UK Amlodipine and Olmesartan Sales and Growth Rate (2015-2020)
6.4 France Amlodipine and Olmesartan Sales and Growth Rate (2015-2020)
6.5 Russia Amlodipine and Olmesartan Sales and Growth Rate (2015-2020)
6.6 Italy Amlodipine and Olmesartan Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Amlodipine and Olmesartan Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Amlodipine and Olmesartan Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Amlodipine and Olmesartan Revenue and Market Share by Regions (2015-2020)
7.2 China Amlodipine and Olmesartan Sales and Growth Rate (2015-2020)
7.3 Japan Amlodipine and Olmesartan Sales and Growth Rate (2015-2020)
7.4 Korea Amlodipine and Olmesartan Sales and Growth Rate (2015-2020)
7.5 India Amlodipine and Olmesartan Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Amlodipine and Olmesartan Sales and Growth Rate (2015-2020)
7.7 Australia Amlodipine and Olmesartan Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Amlodipine and Olmesartan Sales, Revenue and Market Share by Country
8.1.1 South America Amlodipine and Olmesartan Sales and Market Share by Country (2015-2020)
8.1.2 South America Amlodipine and Olmesartan Revenue and Market Share by Country (2015-2020)
8.2 Brazil Amlodipine and Olmesartan Sales and Growth Rate (2015-2020)
8.3 Argentina Amlodipine and Olmesartan Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Amlodipine and Olmesartan Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Amlodipine and Olmesartan Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Amlodipine and Olmesartan Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Amlodipine and Olmesartan Sales and Growth Rate (2015-2020)
9.3 Turkey Amlodipine and Olmesartan Sales and Growth Rate (2015-2020)
9.4 Egypt Amlodipine and Olmesartan Sales and Growth Rate (2015-2020)
9.5 South Africa Amlodipine and Olmesartan Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Amlodipine and Olmesartan Sales and Market Share by Type (2015-2020)
10.2 Global Amlodipine and Olmesartan Revenue and Market Share by Type (2015-2020)
10.3 Global Amlodipine and Olmesartan Price by Type (2015-2020)
11 Global Amlodipine and Olmesartan Market Segment by Application
11.1 Global Amlodipine and Olmesartan Sales Market Share by Application (2015-2020)
11.2 Global Amlodipine and Olmesartan Revenue Market Share by Application (2015-2020)
11.3 Global Amlodipine and Olmesartan Price by Application (2015-2020)
12 Market Forecast
12.1 Global Amlodipine and Olmesartan Sales, Revenue and Growth Rate (2021-2025)
12.2 Amlodipine and Olmesartan Market Forecast by Regions (2021-2025)
12.2.1 North America Amlodipine and Olmesartan Market Forecast (2021-2025)
12.2.2 Europe Amlodipine and Olmesartan Market Forecast (2021-2025)
12.2.3 Asia-Pacific Amlodipine and Olmesartan Market Forecast (2021-2025)
12.2.4 South America Amlodipine and Olmesartan Market Forecast (2021-2025)
12.2.5 Middle East & Africa Amlodipine and Olmesartan Market Forecast (2021-2025)
12.3 Amlodipine and Olmesartan Market Forecast by Type (2021-2025)
12.3.1 Global Amlodipine and Olmesartan Sales Forecast by Type (2021-2025)
12.3.2 Global Amlodipine and Olmesartan Market Share Forecast by Type (2021-2025)
12.4 Amlodipine and Olmesartan Market Forecast by Application (2021-2025)
12.4.1 Global Amlodipine and Olmesartan Sales Forecast by Application (2021-2025)
12.4.2 Global Amlodipine and Olmesartan Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Amlodipine and Olmesartan Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Amlodipine and Olmesartan by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Amlodipine and Olmesartan Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 8. Daiichi Sankyo Amlodipine and Olmesartan Major Business
Table 9. Daiichi Sankyo Amlodipine and Olmesartan Total Revenue (USD Million) (2018-2019)
Table 10. Daiichi Sankyo SWOT Analysis
Table 11. Daiichi Sankyo Amlodipine and Olmesartan Product and Services
Table 12. Daiichi Sankyo Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Alembic Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Alembic Pharmaceuticals Amlodipine and Olmesartan Major Business
Table 15. Alembic Pharmaceuticals Amlodipine and Olmesartan Total Revenue (USD Million) (2018-2019)
Table 16. Alembic Pharmaceuticals SWOT Analysis
Table 17. Alembic Pharmaceuticals Amlodipine and Olmesartan Product and Services
Table 18. Alembic Pharmaceuticals Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Matrix Laboratories Basic Information, Manufacturing Base and Competitors
Table 20. Matrix Laboratories Amlodipine and Olmesartan Major Business
Table 21. Matrix Laboratories Amlodipine and Olmesartan Total Revenue (USD Million) (2018-2019)
Table 22. Matrix Laboratories SWOT Analysis
Table 23. Matrix Laboratories Amlodipine and Olmesartan Product and Services
Table 24. Matrix Laboratories Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Teva Basic Information, Manufacturing Base and Competitors
Table 26. Teva Amlodipine and Olmesartan Major Business
Table 27. Teva Amlodipine and Olmesartan Total Revenue (USD Million) (2018-2019)
Table 28. Teva SWOT Analysis
Table 29. Teva Amlodipine and Olmesartan Product and Services
Table 30. Teva Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Macleods Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Macleods Pharmaceuticals Amlodipine and Olmesartan Major Business
Table 33. Macleods Pharmaceuticals Amlodipine and Olmesartan Total Revenue (USD Million) (2018-2019)
Table 34. Macleods Pharmaceuticals SWOT Analysis
Table 35. Macleods Pharmaceuticals Amlodipine and Olmesartan Product and Services
Table 36. Macleods Pharmaceuticals Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 38. Glenmark Pharmaceuticals Amlodipine and Olmesartan Major Business
Table 39. Glenmark Pharmaceuticals Amlodipine and Olmesartan Total Revenue (USD Million) (2018-2019)
Table 40. Glenmark Pharmaceuticals SWOT Analysis
Table 41. Glenmark Pharmaceuticals Amlodipine and Olmesartan Product and Services
Table 42. Glenmark Pharmaceuticals Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Jubilant Pharma Amlodipine and Olmesartan Major Business
Table 45. Jubilant Pharma Amlodipine and Olmesartan Total Revenue (USD Million) (2018-2019)
Table 46. Jubilant Pharma SWOT Analysis
Table 47. Jubilant Pharma Amlodipine and Olmesartan Product and Services
Table 48. Jubilant Pharma Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Aurobindo Basic Information, Manufacturing Base and Competitors
Table 50. Aurobindo Amlodipine and Olmesartan Major Business
Table 51. Aurobindo Amlodipine and Olmesartan Total Revenue (USD Million) (2018-2019)
Table 52. Aurobindo SWOT Analysis
Table 53. Aurobindo Amlodipine and Olmesartan Product and Services
Table 54. Aurobindo Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Torrent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 56. Torrent Pharmaceuticals Amlodipine and Olmesartan Major Business
Table 57. Torrent Pharmaceuticals Amlodipine and Olmesartan Total Revenue (USD Million) (2018-2019)
Table 58. Torrent Pharmaceuticals SWOT Analysis
Table 59. Torrent Pharmaceuticals Amlodipine and Olmesartan Product and Services
Table 60. Torrent Pharmaceuticals Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Ajanta Pharma Basic Information, Manufacturing Base and Competitors
Table 62. Ajanta Pharma Amlodipine and Olmesartan Major Business
Table 63. Ajanta Pharma Amlodipine and Olmesartan Total Revenue (USD Million) (2018-2019)
Table 64. Ajanta Pharma SWOT Analysis
Table 65. Ajanta Pharma Amlodipine and Olmesartan Product and Services
Table 66. Ajanta Pharma Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Accord Healthcare Basic Information, Manufacturing Base and Competitors
Table 68. Accord Healthcare Amlodipine and Olmesartan Major Business
Table 69. Accord Healthcare Amlodipine and Olmesartan Total Revenue (USD Million) (2018-2019)
Table 70. Accord Healthcare SWOT Analysis
Table 71. Accord Healthcare Amlodipine and Olmesartan Product and Services
Table 72. Accord Healthcare Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Global Amlodipine and Olmesartan Sales by Manufacturer (2018-2019) (K Units)
Table 74. Global Amlodipine and Olmesartan Revenue by Manufacturer (2018-2019) (USD Million)
Table 75. Global Amlodipine and Olmesartan Sales by Regions (2015-2020) (K Units)
Table 76. Global Amlodipine and Olmesartan Sales Market Share by Regions (2015-2020)
Table 77. Global Amlodipine and Olmesartan Revenue by Regions (2015-2020) (USD Million)
Table 78. North America Amlodipine and Olmesartan Sales by Countries (2015-2020) (K Units)
Table 79. North America Amlodipine and Olmesartan Sales Market Share by Countries (2015-2020)
Table 80. North America Amlodipine and Olmesartan Revenue by Countries (2015-2020) (USD Million)
Table 81. North America Amlodipine and Olmesartan Revenue Market Share by Countries (2015-2020)
Table 82. Europe Amlodipine and Olmesartan Sales by Countries (2015-2020) (K Units)
Table 83. Europe Amlodipine and Olmesartan Sales Market Share by Countries (2015-2020)
Table 84. Europe Amlodipine and Olmesartan Revenue by Countries (2015-2020) (USD Million)
Table 85. Asia-Pacific Amlodipine and Olmesartan Sales by Regions (2015-2020) (K Units)
Table 86. Asia-Pacific Amlodipine and Olmesartan Sales Market Share by Regions (2015-2020)
Table 87. Asia-Pacific Amlodipine and Olmesartan Revenue by Regions (2015-2020) (USD Million)
Table 88. South America Amlodipine and Olmesartan Sales by Countries (2015-2020) (K Units)
Table 89. South America Amlodipine and Olmesartan Sales Market Share by Countries (2015-2020)
Table 90. South America Amlodipine and Olmesartan Revenue by Countries (2015-2020) (USD Million)
Table 91. South America Amlodipine and Olmesartan Revenue Market Share by Countries (2015-2020)
Table 92. Middle East & Africa Amlodipine and Olmesartan Sales by Countries (2015-2020) (K Units)
Table 93. Middle East & Africa Amlodipine and Olmesartan Sales Market Share by Countries (2015-2020)
Table 94. Middle East & Africa Amlodipine and Olmesartan Revenue by Countries (2015-2020) (USD Million)
Table 95. Middle East & Africa Amlodipine and Olmesartan Revenue Market Share by Countries (2015-2020)
Table 96. Global Amlodipine and Olmesartan Sales by Type (2015-2020) (K Units)
Table 97. Global Amlodipine and Olmesartan Sales Share by Type (2015-2020)
Table 98. Global Amlodipine and Olmesartan Revenue by Type (2015-2020) (USD Million)
Table 99. Global Amlodipine and Olmesartan Revenue Share by Type (2015-2020)
Table 100. Global Amlodipine and Olmesartan Sales by Application (2015-2020) (K Units)
Table 101. Global Amlodipine and Olmesartan Sales Share by Application (2015-2020)
Table 102. Global Amlodipine and Olmesartan Sales Forecast by Regions (2021-2025) (K Units)
Table 103. Global Amlodipine and Olmesartan Market Share Forecast by Regions (2021-2025)
Table 104. Global Amlodipine and Olmesartan Sales Forecast by Type (2021-2025) (K Units)
Table 105. Global Amlodipine and Olmesartan Market Share Forecast by Type (2021-2025)
Table 106. Global Amlodipine and Olmesartan Sales Forecast by Application (2021-2025)
Table 107. Global Amlodipine and Olmesartan Market Share Forecast by Application (2021-2025)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Amlodipine and Olmesartan Picture
Figure 2. Global Sales Market Share of Amlodipine and Olmesartan by Type in 2019
Figure 3. 5/20 mg Tablets Picture
Figure 4. 10/20 mg Tablets Picture
Figure 5. 5/40 mg Tablets Picture
Figure 6. 10/40 mg Tablets Picture
Figure 7. Amlodipine and Olmesartan Sales Market Share by Application in 2018
Figure 8. Hospital Picture
Figure 9. Drug store Picture
Figure 10. Global Amlodipine and Olmesartan Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Amlodipine and Olmesartan Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Amlodipine and Olmesartan Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Amlodipine and Olmesartan Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Amlodipine and Olmesartan Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Amlodipine and Olmesartan Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Amlodipine and Olmesartan Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Amlodipine and Olmesartan Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Amlodipine and Olmesartan Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Amlodipine and Olmesartan Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Amlodipine and Olmesartan Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Amlodipine and Olmesartan Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Amlodipine and Olmesartan Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Amlodipine and Olmesartan Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Amlodipine and Olmesartan Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Amlodipine and Olmesartan Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Amlodipine and Olmesartan Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Amlodipine and Olmesartan Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Amlodipine and Olmesartan Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Amlodipine and Olmesartan Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Amlodipine and Olmesartan Sales Market Share by Manufacturer in 2019
Figure 31. Global Amlodipine and Olmesartan Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Amlodipine and Olmesartan Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Amlodipine and Olmesartan Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Amlodipine and Olmesartan Sales and Growth Rate (2015-2020) (K Units)
Figure 36. Global Amlodipine and Olmesartan Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Amlodipine and Olmesartan Revenue Market Share by Regions (2015-2020)
Figure 38. Global Amlodipine and Olmesartan Revenue Market Share by Regions in 2018
Figure 39. North America Amlodipine and Olmesartan Sales and Growth Rate (2015-2020)
Figure 40. Europe Amlodipine and Olmesartan Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Amlodipine and Olmesartan Sales and Growth Rate (2015-2020)
Figure 42. South America Amlodipine and Olmesartan Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Amlodipine and Olmesartan Sales and Growth Rate (2015-2020)
Figure 44. North America Amlodipine and Olmesartan Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Amlodipine and Olmesartan Sales Market Share by Countries (2015-2020)
Figure 46. North America Amlodipine and Olmesartan Sales Market Share by Countries in 2018
Figure 47. North America Amlodipine and Olmesartan Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Amlodipine and Olmesartan Revenue Market Share by Countries in 2018
Figure 49. United States Amlodipine and Olmesartan Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Canada Amlodipine and Olmesartan Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Mexico Amlodipine and Olmesartan Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Europe Amlodipine and Olmesartan Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Amlodipine and Olmesartan Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Amlodipine and Olmesartan Revenue Market Share by Countries in 2019
Figure 55. Germany Amlodipine and Olmesartan Sales and Growth Rate (2015-2020) (K Units)
Figure 56. UK Amlodipine and Olmesartan Sales and Growth Rate (2015-2020) (K Units)
Figure 57. France Amlodipine and Olmesartan Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Russia Amlodipine and Olmesartan Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Italy Amlodipine and Olmesartan Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Asia-Pacific Amlodipine and Olmesartan Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Amlodipine and Olmesartan Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Amlodipine and Olmesartan Revenue Market Share by Regions 2019
Figure 63. China Amlodipine and Olmesartan Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Japan Amlodipine and Olmesartan Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Korea Amlodipine and Olmesartan Sales and Growth Rate (2015-2020) (K Units)
Figure 66. India Amlodipine and Olmesartan Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Southeast Asia Amlodipine and Olmesartan Sales and Growth Rate (2015-2020) (K Units)
Figure 68. South America Amlodipine and Olmesartan Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Amlodipine and Olmesartan Sales Market Share by Countries in 2019
Figure 70. South America Amlodipine and Olmesartan Revenue Market Share by Countries in 2019
Figure 71. Brazil Amlodipine and Olmesartan Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Argentina Amlodipine and Olmesartan Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Middle East and Africa Amlodipine and Olmesartan Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Amlodipine and Olmesartan Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Amlodipine and Olmesartan Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Amlodipine and Olmesartan Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Amlodipine and Olmesartan Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Egypt Amlodipine and Olmesartan Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Turkey Amlodipine and Olmesartan Sales and Growth Rate (2015-2020) (K Units)
Figure 80. South Africa Amlodipine and Olmesartan Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Global Amlodipine and Olmesartan Sales and Growth Rate (2021-2025) (K Units)
Figure 82. Global Amlodipine and Olmesartan Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Amlodipine and Olmesartan Market Forecast (2021-2025) (K Units)
Figure 84. Europe Sales Amlodipine and Olmesartan Market Forecast (2021-2025) (K Units)
Figure 85. Asia-Pacific Sales Amlodipine and Olmesartan Market Forecast (2021-2025) (K Units)
Figure 86. South America Sales Amlodipine and Olmesartan Market Forecast (2021-2025) (K Units)
Figure 87. Middle East & Africa Sales Amlodipine and Olmesartan Market Forecast (2021-2025) (K Units)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
アムロジピン-アトルバスタチンの世界市場 2020年 Market Overview The global Amlodipine-Atorvastatin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Amlodipine-Atorvastat…- カルシウム錠剤の世界市場 2020年 Market Overview The Calcium Tablets market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
- 糖衣錠の世界市場 2020年 Market Overview The Sugar Coated Tablets market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- デジタルライティング・グラフィックタブレットの世界市場 2020年 Market Overview The Digital Writing & Graphics Tablets market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain …
- 子供用タブレットの世界市場 2020年 Market Overview The global Children's Tablets market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Children's Tablets market …